Cargando…
A nano-enhanced vaccine for metastatic melanoma immunotherapy
Aim: Despite the huge advancements in cancer therapies and treatments over the past decade, most patients with metastasized melanoma still die from the disease. This poor prognosis largely results from resistance to conventional chemotherapies and other cytotoxic drugs. We have previously identified...
Autores principales: | Salotto, Katelyn E., Olson Jr, Walter C., Pollack, Karlyn E., Illendula, Anuradha, Michel, Elishama, Henriques, Sydney, Fox, Todd, Walker, Susan, Dunlap-Brown, Marya, Slingluff Jr, Craig L., Kester, Mark, Snyder, Helena W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511805/ https://www.ncbi.nlm.nih.gov/pubmed/36176766 http://dx.doi.org/10.20517/cdr.2021.132 |
Ejemplares similares
-
Nanoliposome C6‐Ceramide in combination with anti‐CTLA4 antibody improves anti‐tumor immunity in hepatocellular cancer
por: Qi, Xiaoqiang, et al.
Publicado: (2022) -
Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma
por: Kaufman, Howard L, et al.
Publicado: (2014) -
Incomplete Freund’s adjuvant reduces arginase and enhances Th1 dominance, TLR signaling and CD40 ligand expression in the vaccine site microenvironment
por: Pollack, Karlyn E, et al.
Publicado: (2020) -
Antibody response to melanoma helper-peptide vaccine correlates with survival
por: Olson, Walter C, et al.
Publicado: (2013) -
From bench to bedside a comprehensive review of pancreatic cancer immunotherapy
por: Kunk, Paul R., et al.
Publicado: (2016)